Department of Defense gets $10 million raise to battle prostate cancer
The 2017 Defense Appropriations Bill greenlighted by the Senate last week includes a $10 billion increase, to $90 billion, for the Pentagon’s prostate cancer research program.
“The funding increase means many new prostate cancer research projects this year focused on new treatments and improving diagnosis methods,” says Jamie Bearse, CEO of the group ZERO: The End of Prostate Cancer, in a press release picked up by Prostate Cancer News Today.
The outlet notes that the Pentagon’s medical research programs have led to three new treatments for prostate cancer plus a genetic diagnosis profile.
Read the rest:
Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.